Disclosures for "Is Cladribine a Suitable Strategy after Natalizumab in MS? Real-world Outcomes"
-
Dr. Vachova has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Vachova has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Vachova has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Vachova has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
-
Dr. Stastna has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Stastna has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Stastna has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Stastna has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Stastna has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Stastna has received publishing royalties from a publication relating to health care. Dr. Stastna has received publishing royalties from a publication relating to health care. Dr. Stastna has received publishing royalties from a publication relating to health care.
-
Jiri Drahota has received personal compensation for serving as an employee of IMPULS Endowment Fund. Jiri Drahota has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche s.r.o.. Jiri Drahota has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis s.r.o..
-
Pavel Potuznik has nothing to disclose.
-
Dr. Ampapa has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Ampapa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Ampapa has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Ampapa has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzym. Dr. Ampapa has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Ampapa has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
-
Dr. Dufek has nothing to disclose.
-
Dr. Grunermelova has nothing to disclose.
-
Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
-
Mrs. Houskova has nothing to disclose.
-
Author has nothing to disclose
-
Ms. Libertinova has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Ms. Libertinova has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck Serono. Ms. Libertinova has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche. Ms. Libertinova has received personal compensation in the range of $0-$499 for serving as a Consultant for Bristol Mayer Squibb. Ms. Libertinova has received personal compensation in the range of $0-$499 for serving as a Consultant for Teva.
-
Dr. Martinkova has nothing to disclose.
-
Prof. Pavelek has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Pavelek has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Pavelek has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for bristol myers squibb. Prof. Pavelek has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Pavelek has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva.
-
Marek Peterka has nothing to disclose.
-
Dr. Recmanova has nothing to disclose.
-
Dr. Rous has nothing to disclose.
-
Dr. Rous has nothing to disclose.
-
Ivana Stetkarova, MD, PhD has nothing to disclose.
-
Dr. Stourac has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol- Myers Squibb. Dr. Stourac has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Stourac has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis .
-
Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
-
Mr. Fistravec has received personal compensation for serving as an employee of IMPULS , nadacnà fond.